The diuretic medicine sales in Chile stood at 9.37 billion Chilean Pesos in 2023, marking a slight decrease of 1.36% from the previous year. Over the past decade, the market has experienced fluctuations, including notable growths and declines. From 2018 to 2023, the market generally trended upwards, reflecting a compound annual growth rate (CAGR) of 8.22%. Looking forward, the market is anticipated to continue growing, with a forecasted 5-year CAGR of 4.04%, projecting an increase to 12.1 billion Chilean Pesos by 2028.

Future trends to watch for:

Increasing prevalence of cardiovascular and renal diseases driving medication demand.
New product innovations and improvements in diuretic formulations.
Expansion of healthcare coverage and access in Chile.
Influence of market regulations and pricing policies on pharmaceutical sales.
Potential economic fluctuations impacting disposable incomes and healthcare spending.